PROMETRIKA

Executive Summary

PROMETRIKA is a full-service clinical research organization (CRO) founded in 2003 and headquartered in Cambridge, Massachusetts. The company offers comprehensive clinical development services including clinical operations, data management, biostatistics, medical writing, pharmacovigilance, and regulatory affairs support. It partners with biopharmaceutical and medical device companies to advance therapies from pre-IND stages through Phase 4 post-marketing studies. With over two decades of experience, PROMETRIKA has established itself as a reliable partner in the CRO space, leveraging its expertise to support a range of therapeutic areas. The company's private status and steady operation suggest a stable but not high-growth trajectory, though it benefits from the increasing outsourcing of clinical trials by pharma and biotech firms.

Upcoming Catalysts (preview)

• TBDMajor New Contract Win with Biopharma Client60% success
• TBDExpansion into New Therapeutic Area or Geographic Market40% success
• TBDClient Therapy Achieves Key Regulatory Milestone (e.g., FDA Approval)50% success